Evidence map›Paper›PMID 29475921›Full record

ArticleIn vivo (Athens, Greece)

Clinical Impact of a Surgical Energy Device in Advanced Ovarian Cancer Surgery Including Bowel Resection.

Giuseppe Vizzielli, Carmine Conte, Massimo Romano, Anna Fagotti, Barbara Costantini, Claudio Lodoli, Salvatore Gueli Alletti, Khaled Gaballah, Fabio Pacelli, Alfredo Ercoli and 2 more

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Utilization of LigasureJournal of clinical medicine · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Giuseppe VizzielliDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy giuseppevizzielli@yahoo.it giuseppe.vizzielli@policlinicogemelli.it.
Carmine ConteDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Massimo RomanoDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Anna FagottiDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Barbara CostantiniDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Claudio LodoliDepartment of General Surgery, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Salvatore Gueli AllettiDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Khaled GaballahDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Fabio PacelliDepartment of General Surgery, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Alfredo ErcoliDepartment of Obstetrics and Gynecology, University of Eastern Piedmont, Novara, Italy.
Giovanni ScambiaDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Valerio GallottaDepartment of Women's and Children's Health, Agostino Gemelli University Hospital, Catholic University, Rome, Italy.
Agostino Gemelli University Polyclinic · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. PATIENTS AND

methodsThis was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nerve-sparing surgery was analyzed before and 6 months after surgery.

resultsForty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted.

conclusionCaiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.

Indexed as

AdultAgedAnalysis of VarianceColectomyFemaleGynecologic Surgical ProceduresHumansIntraoperative ComplicationsMiddle AgedNeoplasm StagingOvarian NeoplasmsPostoperative ComplicationsRetreatmentTreatment OutcomeCaiman®energy deviceOvarian cancersurgery

Identifiers

PMID29475921
PMCPMC5905206
OpenAlexW2789078102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.